Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CRH
CRH
|
+$978M |
| 2 |
Microsoft
MSFT
|
+$812M |
| 3 |
Bank of America
BAC
|
+$602M |
| 4 |
Apple
AAPL
|
+$518M |
| 5 |
NVIDIA
NVDA
|
+$412M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.32B |
| 2 |
State Street Materials Select Sector SPDR ETF
XLB
|
+$1.12B |
| 3 |
State Street Communication Services Select Sector SPDR ETF
XLC
|
+$958M |
| 4 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$940M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$816M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.45% |
| 2 | Financials | 11.83% |
| 3 | Healthcare | 11.27% |
| 4 | Consumer Discretionary | 10.12% |
| 5 | Communication Services | 7.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2201
Invesco Solar ETF
TAN
$1.45B
| $1.11M | ﹤0.01% |
21,340
-394
| -2% | -$24.3K |
|
2202
SentinelOne
S
$7.12B
| $1.1M | ﹤0.01% |
65,513
-593,259
| -90% | -$9.37M |
|
2203
Arcutis Biotherapeutics
ARQT
$3.31B
| $1.1M | ﹤0.01% |
207,077
-26,341
| -11% | -$224K |
|
2204
Seres Therapeutics
MCRB
$47.9M
| $1.1M | ﹤0.01% |
23,060
+4,515
| +24% | +$345K |
|
|
HOUS
2205
DELISTED
Anywhere Real Estate
HOUS
| $1.1M | ﹤0.01% |
170,578
-5,839
| -3% | -$42.5K |
|
2206
Empire State Realty Trust
ESRT
$843M
| $1.1M | ﹤0.01% |
136,419
-322,483
| -70% | -$2.69M |
|
2207
Amphastar Pharmaceuticals
AMPH
$873M
| $1.09M | ﹤0.01% |
23,793
-6,464
| -21% | -$353K |
|
2208
StoneCo
STNE
$2.69B
| $1.09M | ﹤0.01% |
102,349
+9,514
| +10% | +$117K |
|
2209
CVR Energy
CVI
$3.15B
| $1.09M | ﹤0.01% |
32,066
-70,142
| -69% | -$2.4M |
|
2210
Oxford Industries
OXM
$560M
| $1.09M | ﹤0.01% |
11,342
-76
| -0.7% | -$7.71K |
|
2211
DigitalBridge
DBRG
$2.95B
| $1.09M | ﹤0.01% |
61,810
-311,689
| -83% | -$5.15M |
|
|
PFC
2212
DELISTED
Premier Financial Corp. Common Stock
PFC
| $1.09M | ﹤0.01% |
63,684
+1,698
| +3% | +$31.9K |
|
2213
Skywest
SKYW
$4.4B
| $1.09M | ﹤0.01% |
25,891
-7,998
| -24% | -$336K |
|
2214
Viasat
VSAT
$11.3B
| $1.09M | ﹤0.01% |
58,793
+18,382
| +45% | +$526K |
|
|
SLRN
2215
DELISTED
ACELYRIN
SLRN
| $1.09M | ﹤0.01% |
+106,688
| New | +$2.27M |
|
|
DDL
2216
Dingdong
DDL
$490M
| $1.08M | ﹤0.01% |
555,613
| – | – |
|
2217
Cogent Biosciences
COGT
$7.14B
| $1.08M | ﹤0.01% |
110,912
-1,481
| -1% | -$17.6K |
|
2218
Scotiabank
BNS
$108B
| $1.08M | ﹤0.01% |
23,676
-115,294
| -83% | -$5.52M |
|
2219
Applied Optoelectronics
AAOI
$9.97B
| $1.08M | ﹤0.01% |
98,350
+16,153
| +20% | +$171K |
|
2220
Capitol Federal Financial
CFFN
$1.11B
| $1.08M | ﹤0.01% |
225,578
-25,162
| -10% | -$149K |
|
|
BIG
2221
DELISTED
Big Lots, Inc.
BIG
| $1.07M | ﹤0.01% |
210,277
+152,677
| +265% | +$1.16M |
|
2222
DocGo
DCGO
$61.7M
| $1.07M | ﹤0.01% |
201,583
+167,626
| +494% | +$1.36M |
|
2223
Monarch Casino & Resort
MCRI
$2.19B
| $1.07M | ﹤0.01% |
17,295
-2,682
| -13% | -$181K |
|
|
CCRN
2224
DELISTED
Cross Country Healthcare
CCRN
| $1.07M | ﹤0.01% |
43,263
+11,718
| +37% | +$295K |
|
2225
Allegiant Air
ALGT
$2.61B
| $1.07M | ﹤0.01% |
13,937
+3,336
| +31% | +$343K |
|
Similar funds
Barclays's Q3 2023 Portfolio in Review
As of Q3 2023, Barclays held 4,832 positions worth $161B, up 1.7% from $158B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Barclays deployed $8.05B of net new capital in Q3 2023, opening 336 new positions and adding to 1,838 existing holdings. Its largest new stake was CRH: 17,203,754 shares worth $942M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 28% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $1.32B trimmed.
- Barclays's largest Q3 2023 buy was CRH: 17,203,754 shares worth $942M.
- Barclays added most to Microsoft in Q3 2023, an estimated $812M increase.
- Barclays's biggest Q3 2023 reduction was Invesco QQQ Trust, cutting an estimated $1.32B.
- Barclays fully exited Aerojet Rocketdyne Holdings in Q3 2023, selling an estimated $154M.
- Barclays's ten largest holdings make up 24% of its $161B portfolio in Q3 2023.
- Barclays opened 336 new positions and closed 249 in Q3 2023.
- Barclays's portfolio value rose 1.7% quarter-over-quarter to $161B.
Based on Barclays's 13F filing for Q3 2023, filed 7 Nov 2023.